A Study to Evaluate the Immunogenicity and Safety of an EV71 Vaccine (Envacgen®) in Children Aged 6 to <10 Years Compared to Children Aged 2 to <6 Years

Clinical trial NCT07178522 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT07178522
Sponsor: Medigen Vaccine Biologics Corp.
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Enterovirus 71 Inactivated Vaccine

Start date: 2025-06-25
Primary completion: 2026-07-31
Enrollment: 378

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.